Long-term use of proton pump inhibitors is associated with a greater number of asthma exacerbations, according to reporting by HCPLive published on October 18, 2026. The outlet framed the finding around chronic use of the medications, which are widely prescribed for acid-related conditions.
The report presents the connection as a link rather than a proven cause. HCPLive's summary does not include the size of the study population, the specific drugs examined, or the magnitude of the difference in flare-ups, and those details were not available in the material reviewed.
Proton pump inhibitors are a common class of acid-suppressing drugs, and the HCPLive report focuses on what happens when they are taken over an extended period rather than briefly. The headline and summary do not specify whether the patients studied had pre-existing asthma or how exacerbations were defined or measured.
Because only the headline and summary were available, questions about the study design, the patient group, and whether other factors were accounted for remain unanswered in this report. Readers should treat the finding as an reported association that has not been detailed in the material available here.
Watch for the full HCPLive article or the underlying study for the patient numbers, the drugs involved, and any guidance on whether asthma patients on long-term acid suppression should review their prescriptions with a clinician.
